神經分泌生物科學公司 - 資產負債表 (Quarterly)

神經分泌生物科學公司
GB ˙ LSE ˙ US64125C1099
US$166.27 ↓ -1.53 (-0.91%)
2026-06-05
分享價格
資產負債表 (Quarterly)

神經分泌生物科學公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 368 311 341 270 163 212 263 104 160 294 251 396 140 349 233 194 264 340 713 266
改變 (%) -15.46 9.55 -20.72 -39.56 29.94 23.89 -60.52 54.34 83.33 -14.50 57.83 -64.75 149.89 -33.26 -16.70 36.01 28.86 109.58 -62.62
流動資產 1,110 1,006 973 1,018 1,019 1,206 1,454 1,433 1,497 1,650 1,607 1,799 1,670 1,877 1,725 1,638 1,749 2,158 2,523 2,436
改變 (%) -9.40 -3.27 4.67 0.11 18.27 20.57 -1.42 4.45 10.24 -2.60 11.95 -7.18 12.38 -8.09 -5.03 6.78 23.41 16.88 -3.43
資產 1,956 2,017 2,072 2,144 2,006 2,143 2,369 2,360 2,613 2,848 3,251 3,472 3,305 3,535 3,719 3,688 3,890 4,266 4,632 4,906
改變 (%) 3.11 2.74 3.47 -6.47 6.87 10.51 -0.38 10.73 9.00 14.16 6.80 -4.82 6.96 5.20 -0.83 5.48 9.66 8.58 5.93
負債 677 671 698 753 582 599 661 675 760 846 1,019 1,086 796 816 1,129 1,152 1,196 1,262 1,378 1,499
改變 (%) -0.87 4.05 7.86 -22.71 2.83 10.37 2.18 12.56 11.31 20.48 6.56 -26.74 2.55 38.34 2.04 3.78 5.57 9.21 8.73
公平 1,279 1,346 1,374 1,391 1,423 1,545 1,708 1,684 1,853 2,002 2,232 2,386 2,509 2,719 2,590 2,536 2,694 3,004 3,253 3,407
改變 (%) 5.22 2.08 1.24 2.32 8.51 10.57 -1.36 10.00 8.05 11.48 6.90 5.16 8.36 -4.75 -2.09 6.25 11.48 8.31 4.74
負債和股本 1,956 2,017 2,072 2,144 2,006 2,143 2,369 2,360 2,613 2,848 3,251 3,472 3,305 3,535 3,719 3,688 3,890 4,266 4,632 4,906
改變 (%) 3.11 2.74 3.47 -6.47 6.87 10.51 -0.38 10.73 9.00 14.16 6.80 -4.82 6.96 5.20 -0.83 5.48 9.66 8.58 5.93

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:NB3 €134.65
IT:1NBIX €144.05
US:NBIX US$163.88
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista